Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001104659-21-042628

Options or other derivatives

  • Chief Financial Officer acquired 56,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Martin Steven Robert Chief Financial Officer 2021-03-25 Grant or award · Stock Option (Right to Buy) +56,000 56,000 D: show line 1 in the form
Loading xslF345X03/tm2111079-1_4seq1.xml…